Carsten Brunn, President and CEO at Cartesian Therapeutics, Inc. (RNAC), sold 23,766 shares at $6.82 ($162K) on 2026-01-06, disclosed to the SEC on 2026-01-08.
Open-market sale of $162k RNAC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SELB | SELL | 2023-01-06 | $46K | — | Filing → |
| SELB | SELL | 2022-12-07 | $6K | — | Filing → |
| SELB | SELL | 2022-09-30 | $4K | — | Filing → |